Taconic Investment Partners and Silverstein Properties , joint venture owners of The Hudson Research Center at 619 West 54th Street, have signed a lease with HiberCell, a newly launched biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis.
HiberCell will occupy a 15,000 s/f pre-built wet lab and office suite on the building’s 8th floor, which is under construction and expected to be completed in April.
The space is part of the developers’ larger initiative to create over 100,000 s/f of research space in the building over the next two years.
The development of The Hudson Research Center aligns with the city’s ongoing initiatives to expand Manhattan’s life sciences sector in an effort to compete with industry-leading cities such as Boston and San Francisco. In 2016, Mayor Bill de Blasio announced a $500 million initiative called LifeSci NYC to boost the life sciences industry in New York City. Additionally, Governor Andrew Cuomo announced a $650 million plan to encourage development of the life science sector statewide.
“The building’s current portfolio of tenants, supportive infrastructure for scientific research, development efforts and prime location in the heart of Manhattan’s thriving West Side have proven to be very attractive to prospective research companies,” said Marty Burger, CEO of Silverstein Properties. “We believe in the building’s ability to serve as the future hub for biotech companies in New York City.”